UPDATE: Turning Point Therapeutics Inc. (TPTX) Announces Proposed Common Share Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Turning Point Therapeutics Inc. (TPTX) Prices 5.42M Share Common Offering at $60/Sh
May 19, 2020 5:43 AM EDTTurning Point Therapeutics, Inc. (NASDAQ: TPTX) today announced the pricing of its previously announced underwritten public offering of 5,416,667 shares of its common stock at a price to the public of $60.00 per share. The gross proceeds to Turning Point from the offering, before deducting underwriting... More
Turning Point Therapeutics Inc. (TPTX) PT Raised to $75 at Roth Capital
May 14, 2020 7:10 AM EDTRoth Capital analyst Zegbeh Jallah raised the price target on Turning Point Therapeutics Inc. (NASDAQ: TPTX) to $75.00 (from $65.00) while maintaining a Buy rating.... More
